THRX News

Eight IPOs joined the public market this past week, joined by ten SPACs. Two companies postponed, both citing market conditions: fitness equipment brand iFIT Health & Fitness (IFIT) and drug developer AEON Biopharma (AEON). New filers continued to flood the pipeline, with 22 IPOs and 12 SPACs submitting initial filings. Canada-listed...read more

Theseus Pharmaceuticals, a preclinical biotech developing pan-variant kinase inhibitors for solid tumors, raised $160 million by offering 10 million shares at $16, the high end of the $14 to $16 range. The company sold 20% more shares than anticipated, according to a form S-1MEF filed Wednesday. Theseus Pharma is focused on developing "pan-variant" kinase inhibitors for cancers....read more

Updated Monday, 10/4. In the first full week of October, seven IPOs are slated to raise $2.0 billion, led by two fitness companies. Fitness chain Life Time Group Holdings (LTH) plans to raise $901 million at a $4.1 billion market cap. Taken private in 2015, Life Time operates more than 150 "centers" across 29 US states and one province in Canada,...read more

Theseus Pharmaceuticals, a preclinical biotech developing pan-variant kinase inhibitors for solid tumors, announced terms for its IPO on Thursday. The Cambridge, MA-based company plans to raise $125 million by offering 8.3 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Theseus Pharmaceuticals would command a fully diluted market value of $593...read more